Skip to content
2000
Volume 33, Issue 5
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

Diabetes mellitus (DM) is a chronic metabolic disorder that seeks treatment instead of available mitigative therapy.

Methods

Six ()-3-(aryl)-1-phenylprop-2-en-1-one chalcones were synthesized and characterized through various spectroscopic techniques. Their anti-diabetic potential was examined through (α-glucosidase and α-amylase inhibition assays), (alloxan-induced hyperglycemia), and studies.

Results

All the chalcones derivatives significantly inhibited α-glucosidase and α-amylase. Compounds (IC = 1.10 ± 0.02) and (IC = 3.25 ± 0.10 µM) exhibited the most potent activity against α-glucosidase. The effect of compounds and was also significant against α-amylase with IC of 13.2 ± 0.50 and 10.2 ± 0.4 µM, respectively. In alloxan-induced hyperglycemic model, a significant (<0.001) reduction in blood glucose level (BGL) was observed by compounds , and with maximum percent inhibition of 47.48, 47.22 and 47.55, respectively. In the oral glucose tolerance test, a continuous reduction in BGL was noted at 60 minutes. No negative effect was seen on lipid profile, and in liver and renal function tests. However, a slight gain in body weight was noted. Moreover, docking result indicates good interaction of these molecules with the target enzymes, α-glucosidase and α-amylase.

Conclusion

These results demonstrate that all these molecules have significant anti-diabetic potential.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673343058250127103657
2025-06-24
2026-02-25

  • From This Site

    /content/journals/cmc/10.2174/0109298673343058250127103657
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. RachidA. RabahD. FaridL. ZohraS.F. HoucineB. NacéraB. Ethnopharmacological survey of medicinal plants used in the traditional treatment of diabetes mellitus in the North Western and South Western Algeria.J. Med. Plants Res.201261020412050
     [Google Scholar]
  2. SingabA.N. YoussefF.S. AshourM.L. Medicinal plants with potential antidiabetic activity and their assessment.Med. Aromat. Plants2014315121670412
     [Google Scholar]
  3. TranN. PhamB. LeL. Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery.Biology20209925210.3390/biology909025232872226
     [Google Scholar]
  4. GüemesM. RahmanS.A. HussainK. What is a normal blood glucose?Arch. Dis. Child.2016101656957410.1136/archdischild‑2015‑30833626369574
     [Google Scholar]
  5. JaraldE. JoshiS.B. JainD. Diabetes and herbal medicines.J. Clin. Biochem. Nutr.200840316317310.3164/jcbn.40.16318398493
     [Google Scholar]
  6. AhmadJ. RafatD. HbA1c and iron deficiency: A review.Diabetes Metab. Syndr.20137211812210.1016/j.dsx.2013.02.00423680254
     [Google Scholar]
  7. WildS. RoglicG. GreenA. SicreeR. KingH. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030.Diabetes Care20042751047105310.2337/diacare.27.5.104715111519
     [Google Scholar]
  8. PatilC.B. MahajanS. KattiS.A. A versatile molecule.J. Pharma. Sci. Res.20091311
     [Google Scholar]
  9. ZafarJ. NadeemD. KhanS.A. Jawad AbbasiM.M. AzizF. SaeedS. Prevalence of diabetes and its correlates in urban population of Pakistan: A Cross-sectional survey.J. Pak. Med. Assoc.201666892292727524520
     [Google Scholar]
  10. BagriP. AliM. AeriV. BhowmikM. Isolation and antidiabetic activity of new lanostenoids from the leaves of Psidium guajava L.Int. J. Pharm. Pharm. Sci.201689141810.22159//ijpps.2016.v8i9.10425
     [Google Scholar]
  11. Welday KahssayS. HailuG.S. Taye DestaK. Design, synthesis, characterization and in vivo antidiabetic activity evaluation of some chalcone derivatives.Drug Des. Devel. Ther.2021153119312910.2147/DDDT.S31618534305396
     [Google Scholar]
  12. GomesM. MuratovE. PereiraM. PeixotoJ. RossetoL. CravoP. AndradeC. NevesB. Chalcone derivatives: Promising starting points for drug design.Molecules2017228121010.3390/molecules2208121028757583
     [Google Scholar]
  13. KatsoriA.M. Hadjipavlou-LitinaD. Recent progress in therapeutic applications of chalcones.Expert Opin. Ther. Pat.201121101575159610.1517/13543776.2011.59652921711087
     [Google Scholar]
  14. MatosM.J. Vazquez-RodriguezS. UriarteE. SantanaL. Potential pharmacological uses of chalcones: A patent review (from June 2011 – 2014).Expert Opin. Ther. Pat.201525335136610.1517/13543776.2014.99562725598152
     [Google Scholar]
  15. De Freitas SilvaM. PruccoliL. MorroniF. SitaG. SeghettiF. ViegasC.Jr TarozziA. The Keap1/Nrf2-ARE pathway as a pharmacological target for chalcones.Molecules2018237180310.3390/molecules2307180330037040
     [Google Scholar]
  16. TsukiyamaR.I. KatsuraH. TokurikiN. KobayashiM. Antibacterial activity of licochalcone A against spore-forming bacteria.Antimicrob. Agents Chemother.20024651226123010.1128/AAC.46.5.1226‑1230.200211959549
     [Google Scholar]
  17. KolbeL. ImmeyerJ. BatzerJ. WensorraU. DieckK. MundtC. WolberR. StäbF. SchönrockU. CeilleyR.I. WenckH. Anti-inflammatory efficacy of Licochalcone A: Correlation of clinical potency and in vitro effects.Arch. Dermatol. Res.20062981233010.1007/s00403‑006‑0654‑416552540
     [Google Scholar]
  18. GirisaS. SaikiaQ. BordoloiD. BanikK. MonishaJ. DaimaryU.D. VermaE. AhnK.S. KunnumakkaraA.B. Xanthohumol from Hop: Hope for cancer prevention and treatment.IUBMB Life20217381016104410.1002/iub.252234170599
     [Google Scholar]
  19. Carmona-GutierrezD. ZimmermannA. KainzK. PietrocolaF. ChenG. MaglioniS. SchiaviA. NahJ. MertelS. BeuschelC.B. CastoldiF. SicaV. TrausingerG. RamlR. SommerC. SchroederS. HoferS.J. BauerM.A. PendlT. TadicJ. DammbrueckC. HuZ. RuckenstuhlC. EisenbergT. DurandS. BossutN. AprahamianF. AbdellatifM. SedejS. EnotD.P. WolinskiH. DengjelJ. KeppO. MagnesC. SinnerF. PieberT.R. SadoshimaJ. VenturaN. SigristS.J. KroemerG. MadeoF. The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species.Nat. Commun.201910165110.1038/s41467‑019‑08555‑w30783116
     [Google Scholar]
  20. SahuN.K. BalbhadraS.S. ChoudharyJ. KohliD.V. Exploring pharmacological significance of chalcone scaffold: A review.Curr. Med. Chem.201219220922510.2174/09298671280341413222320299
     [Google Scholar]
  21. MahapatraD.K. AsatiV. BhartiS.K. Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives.Eur. J. Med. Chem.20159283986510.1016/j.ejmech.2015.01.05125638569
     [Google Scholar]
  22. Kurşun-AktarB.S. AdemŞ. Tatar-YilmazG. HameedZ.A.H. Oruç-EmreE.E. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.J. Mol. Recognit.20233611e306110.1002/jmr.306137720970
     [Google Scholar]
  23. LvS.Y. ChengL.P. Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors.Future Med. Chem.202416131333134510.1080/17568919.2024.234709239109435
     [Google Scholar]
  24. Al-ghulikahH.A. MughalE.U. ElkaeedE.B. NaeemN. NazirY. AlzahraniA.Y.A. SadiqA. ShahS.W.A. Discovery of chalcone derivatives as potential α-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia.J. Mol. Struct.2023127513465810.1016/j.molstruc.2022.134658
     [Google Scholar]
  25. ur RashidH. XuY. AhmadN. MuhammadY. WangL. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E2, inducible NO synthase and nuclear factor κb activities.Bioorg. Chem.20198733536510.1016/j.bioorg.2019.03.03330921740
     [Google Scholar]
  26. RamalhoS.D. BernadesA. DemetriusG. Noda-PerezC. VieiraP.C. dos SantosC.Y. da SilvaJ.A. de MoraesM.O. MousinhoK.C. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation.Chem. Biodivers.201310111999200610.1002/cbdv.20120034424243608
     [Google Scholar]
  27. MousaM.N. MuhasinR.J. AlrubaieL.A.R. Synthesis and assessment of anti-inflammatory activity of a chlorosubstituted chalcone derivatives and using the semi-empirical methods to measure the linked physicochemical parameters.J. Pharm. Biomed. Sci.2016611
     [Google Scholar]
  28. TalniyaN.C. SoodP. Synthesis and antimicrobial activity of chalcones.J. Chem. Pharm. Res.20168561061326867972
     [Google Scholar]
  29. KumarV. KumarS. HassanM. WuH. ThimmulappaR.K. KumarA. SharmaS.K. ParmarV.S. BiswalS. MalhotraS.V. Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells.J. Med. Chem.201154124147415910.1021/jm200234821539383
     [Google Scholar]
  30. MamedaN. PerakaS. KodumuriS. ChevellaD. BanothuR. AmruthamV. NamaN. Synthesis of α,β-unsaturated ketones from alkynes and aldehydes over Hβ zeolite under solvent-free conditions.RSC Advances2016663581375814110.1039/C6RA11593D
     [Google Scholar]
  31. ZhaoY. SongQ. Copper-catalyzed tandem A3-coupling–isomerization–hydrolysis reactions of aldehydes and terminal alkynes leading to chalcones.Org. Chem. Front.20163329429710.1039/C5QO00282F
     [Google Scholar]
  32. DuhanM. KumarP. SindhuJ. SinghR. DeviM. KumarA. KumarR. LalS. Exploring biological efficacy of novel benzothiazole linked 2,5-disubstituted-1,3,4-oxadiazole hybrids as efficient α-amylase inhibitors: Synthesis, characterization, inhibition, molecular docking, molecular dynamics and Monte Carlo based QSAR studies.Comput. Biol. Med.202113810487610.1016/j.compbiomed.2021.10487634598068
     [Google Scholar]
  33. KumarP. DuhanM. KadyanK. SindhuJ. KumarS. SharmaH. Synthesis of novel inhibitors of α-amylase based on the thiazolidine-4-one skeleton containing a pyrazole moiety and their configurational studies.MedChemComm.2017871468147610.1039/C7MD00080D30108858
     [Google Scholar]
  34. KayaG. NomaS.A.A. Barut CelepciD. Bayılİ. Taskin-TokT. GökY. AteşB. AktaşA. AygünM. TezcanB. Design, synthesis, spectroscopic characterizations, single crystal X-ray analysis, in vitro xanthine oxidase and acetylcholinesterase inhibitory evaluation as well as in silico evaluation of selenium-based N -heterocyclic carbene compounds.J. Biomol. Struct. Dyn.20234121117281174710.1080/07391102.2022.216369636622368
     [Google Scholar]
  35. UllahS. WaqasM. HalimS.A. KhanI. KhalidA. AbdallaA.N. MakeenH.A. IbrarA. KhanA. Al-HarrasiA. Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations.Int. J. Biol. Macromol.202325012622710.1016/j.ijbiomac.2023.12622737558024
     [Google Scholar]
  36. KhanH.A. GhufranM. ShamsS. JamalA. AyazM. UllahM. KhanA. KhanM.I. AwanZ.A. In-depth in vitro and in vivo anti-diabetic evaluations of Fagonia cretica mediated biosynthesized selenium nanoparticles.Biomed. Pharmacother.202316411487210.1016/j.biopha.2023.11487237245338
     [Google Scholar]
  37. AssadT. KhanR.A. FerozZ. Evaluation of hypoglycemic and hypolipidemic activity of methanol extract of Brassica oleracea.Chin. J. Nat. Med.201412964865310.1016/S1875‑5364(14)60099‑625263975
     [Google Scholar]
  38. AhmadW. KhanI. KhanM.A. AhmadM. SubhanF. KarimN. Evaluation of antidiabetic and antihyperlipidemic activity of Artemisia indica linn (aeriel parts) in Streptozotocin induced diabetic rats.J. Ethnopharmacol.2014151161862310.1016/j.jep.2013.11.01224252495
     [Google Scholar]
  39. QaziN. KhanR.A. RizwaniG.H. FerozZ. Effect of Carthamus tinctorius (Safflower) on fasting blood glucose and insulin levels in alloxan induced diabetic rabbits.Pak. J. Pharm. Sci.201427237738024577929
     [Google Scholar]
  40. OkoliC. IbiamA. EzikeA. AkahP. OkoyeT. Evaluation of antidiabetic potentials of Phyllanthus niruri in alloxan diabetic rats.Afr. J. Biotechnol.201092
     [Google Scholar]
  41. AkhtarM.S. AhmedM. GulzarK. AdnanH. Hypoglycemic activity of Dodonaea viscosa leaves in normal and alloxan-induced diabetic rabbits.Diabetol. Croat.20114037179
     [Google Scholar]
  42. AghajanyanA. MovsisyanZ. TrchounianA. Antihyperglycemic and antihyperlipidemic activity of hydroponic stevia rebaudiana aqueous extract in hyperglycemia induced by immobilization stress in rabbits.Biomed. Res. Int.20172017925135810.1155/2017/9251358
     [Google Scholar]
  43. LiuM. ZhangW. WeiJ. LinX. Synthesis and α-glucosidase inhibitory mechanisms of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, a potential marine bromophenol α-glucosidase inhibitor.Mar. Drugs2011991554156510.3390/md909155422131958
     [Google Scholar]
  44. SharmaR. ChatterjeeE. MathewJ. SharmaS. RaoN.V. PanC.H. LeeS.B. DhingraA. GrewalA.S. LiouJ.P. GuruS.K. NepaliK. Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier.Eur. J. Med. Chem.202224011460210.1016/j.ejmech.2022.11460235858522
     [Google Scholar]
  45. SharmaR. ChiangY.H. ChenH.C. LinH.Y. YangW.B. NepaliK. LaiM.J. ChenK.Y. LiouJ.P. HsuT.I. Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress.Cancer Lett.202458621666610.1016/j.canlet.2024.21666638311053
     [Google Scholar]
  46. Kar MahapatraD. AsatiV. BhartiS.K. An updated patent review of therapeutic applications of chalcone derivatives (2014-present).Expert Opin. Ther. Pat.201929538540610.1080/13543776.2019.161337431030616
     [Google Scholar]
  47. NairS.S. KavrekarV. MishraA. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts.Eur. J. Exp. Biol.201331128132
     [Google Scholar]
  48. FrödeT.S. MedeirosY.S. Animal models to test drugs with potential antidiabetic activity.J. Ethnopharmacol.2008115217318310.1016/j.jep.2007.10.03818068921
     [Google Scholar]
  49. Chaimum-aomN. ChomkoS. TalubmookC. Toxicology and oral glucose tolerance test (OGTT) of Thai medicinal plant used for diabetes controls, Phyllanthus acidus L.(Euphorbiaceae).Pharmacogn. J.201691586110.5530/pj.2017.1.11
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673343058250127103657
Loading
Synthesis of (E)-3-(aryl)-1-phenylprop-2-en-1-one Chalcone Derivatives for Hyperglycemic Effect in Diabetes: In Vitro, In Vivo and In Silico Approach
Curr. Med. Chem. 33, 1076 (2026); https://doi.org/10.2174/0109298673343058250127103657
/content/journals/cmc/10.2174/0109298673343058250127103657
/content/journals/cmc/10.2174/0109298673343058250127103657
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): anti-diabetic activities; B-cells; chalcone derivatives; Synthesis; α-amylase; α-glucosidase inhibition

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test